Search

Your search keyword '"Francis Lorge"' showing total 3 results
Start Over Author "Francis Lorge" Journal urology
3 results on '"Francis Lorge"'

1. Laparoscopic nephrolithotomy: The value of intracorporeal sonography and color doppler

Author

Antoine S. Abi Aad, Paul Van Cangh, Francis Lorge, Renier Opsomer, and Francois X. Wese

Subjects
Adult, Male, medicine.medical_specialty, Percutaneous, medicine.diagnostic_test, business.industry, Urology, medicine.medical_treatment, Open surgery, Color doppler, Lithotripsy, Kidney Calices, Extracorporeal, Lithotomy position, Surgery, Kidney Calculi, medicine, Humans, Laparoscopy, Ultrasonography, Doppler, Color, business, Nephrotomy, Nephrostomy, Percutaneous
Abstract

Laparoscopic nephrolithotomy was used as an alternative to open surgery in a patient who had failed extracorporeal shock-wave lithotripsy and whose anteriorly located stone-bearing calix precluded percutaneous extraction. Endocavitary ultrasonography and color Doppler render the procedure safe and effective; localization of the stone, selection of an optimal nephrotomy site away from large vessels and where cortical thickness is minimal, and control of fragment clearance are greatly facilitated.

Published
1995
Full Text
View/download PDF

2. Undetectable prostate-specific antigen in aging men

Author

Paul Van Cangh, Reinier Opsomer, Francois X. Wese, A. Abi-Aad, and Francis Lorge

Subjects
Aged, 80 and over, Male, medicine.medical_specialty, business.industry, Prostatic disease, Urology, Reproducibility of Results, Middle Aged, Prostate-Specific Antigen, Prostate-specific antigen, Endocrinology, Antigen, Internal medicine, Prostatic surgery, Humans, Medicine, business, Aged, Hormone
Abstract

Undetectable prostate-specific antigen was found in three aging men despite the absence of any prostatic surgery or exogenous hormonal deprivation. Clinical and elementary hormonal workup revealed the presence of secondary hypogonadism. This finding confirms the hormonal dependency of this prostatic marker and may, in some cases, explain the discrepancy between prostatic volume and the value of serum prostate-specific antigen.

Published
1994
Full Text
View/download PDF

3. Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

Author

Francis Lorge, Paul Van Cangh, Bertrand Tombal, Philippe Sauvage, Francois X. Wese, Luc De Vischer, Philippe De Nayer, and Reinier Opsomer

Subjects
Male, medicine.medical_specialty, Adenoma, Urology, Prostatic Hyperplasia, urologic and male genital diseases, Sensitivity and Specificity, Diagnosis, Differential, Prostate cancer, Prostate, medicine, Humans, Aged, Gynecology, Aged, 80 and over, Receiver operating characteristic, business.industry, Cancer, Prostatic Neoplasms, Hyperplasia, Middle Aged, Prostate-Specific Antigen, medicine.disease, Prostate-specific antigen, medicine.anatomical_structure, Benign prostatic hyperplasia (BPH), business
Abstract

Objectives. Improved discrimination between prostate cancer (PC) and benign prostatic hyperplasia (BPH) is clearly needed. Our aim in this study was to evaluate whether the free to total prostate-specific antigen (PSA) ratio would be useful in the gray zone of 1.8-10 ng/mL total PSA range. Methods. In a consecutive series of 435 clinic patients referred for prostate evaluation, 308 had a total PSA

Published
1996

Catalog

Books, media, physical & digital resources
See catalog results